These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 10993657)

  • 1. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.
    Wild R; Dhanabal M; Olson TA; Ramakrishnan S
    Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
    Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
    J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin.
    Hoffmann S; Masood R; Zhang Y; He S; Ryan SJ; Gill P; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2389-93. PubMed ID: 10892888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
    Zilberberg L; Shinkaruk S; Lequin O; Rousseau B; Hagedorn M; Costa F; Caronzolo D; Balke M; Canron X; Convert O; Laïn G; Gionnet K; Goncalvès M; Bayle M; Bello L; Chassaing G; Deleris G; Bikfalvi A
    J Biol Chem; 2003 Sep; 278(37):35564-73. PubMed ID: 12837752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells.
    Arora N; Masood R; Zheng T; Cai J; Smith DL; Gill PS
    Cancer Res; 1999 Jan; 59(1):183-8. PubMed ID: 9892205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M; Belleri M; Vacca A; Ribatti D
    Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate.
    Olson TA; Mohanraj D; Roy S; Ramakrishnan S
    Int J Cancer; 1997 Dec; 73(6):865-70. PubMed ID: 9399667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
    Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
    Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
    Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
    Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
    DeFouw LM; DeFouw DO
    Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
    Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane.
    Wilting J; Birkenhäger R; Eichmann A; Kurz H; Martiny-Baron G; Marmé D; McCarthy JE; Christ B; Weich HA
    Dev Biol; 1996 May; 176(1):76-85. PubMed ID: 8654896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.
    Ehrbar M; Djonov VG; Schnell C; Tschanz SA; Martiny-Baron G; Schenk U; Wood J; Burri PH; Hubbell JA; Zisch AH
    Circ Res; 2004 Apr; 94(8):1124-32. PubMed ID: 15044320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.